Dr. Paul Allan Kirschbaum, MD

Dr. Kirschbaum practices at Emory University Hospital in Atlanta, Georgia, part of Emory University.

Dr. Kirschbaum's NPI, 1841214822, was assigned on July 26, 2006. Dr. Kirschbaum graduated from Albert Einstein College of Medicine of Yeshiva University in 1979. Dr. Kirschbaum holds Georgia license 021728.

Dr. Kirschbaum's primary practice is Emory University Hospital, at 1364 Clifton Road, NE, Atlanta, GA 30322 in De Kalb County. The practice phone is (404) 686-8500.

Dr. Kirschbaum's primary practice is Emory University Hospital in Atlanta, Georgia, part of Emory University. Dr. Kirschbaum is also affiliated with Northside Hospital Atlanta. The medical group on file is Emory Clinic. Dmand AI also links Dr. Kirschbaum to 3 more hospitals, 1 group practice or clinic, 1 ambulatory surgery center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kirschbaum practices, 7 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Kirschbaum's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Kirschbaum is licensed in Georgia.

CMS data shows 1,813 Medicare services from Dr. Kirschbaum across 20 procedure codes in 2024, for 812 Medicare patients. Medicare paid $89,303 for them.

CMS counts 812 Medicare patients who saw Dr. Kirschbaum in 2024. The largest group is 65 to 74, with 306 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kirschbaum's median patient age at 73, with 55% women.

In 2024, Dr. Kirschbaum wrote 5,984 Medicare Part D claims for 872 patients. 78% of them were for generic drugs. CMS names the drug for 5,724 of them, across 56 drugs with 11 or more claims each, at $1,372,615 in total drug cost. In 2023, CMS named 5,293 claims across 56 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Kirschbaum for performance year 2024, reported through an alternative payment model (APM). Dr. Kirschbaum accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 10 general payments to Dr. Kirschbaum from 3 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 100% of the total. Medtronic Vascular, Inc. paid the most, $162.

Dr. Kirschbaum graduated from Albert Einstein College of Medicine of Yeshiva University in 1979.